MM
IART icon

MQS Management’s Integra LifeSciences IART Stock Holding History

MQS Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,731
Closed -$203K – 527
2024
Q1 		$203K Buy
+5,731
New +$229K 0.12% 372
2022
Q4 		– Sell
-8,192
Closed -$347K – 471
2022
Q3 		$347K Buy
8,192
+3,724
+83% +$191K 0.22% 173
2022
Q2 		$241K Sell
4,468
-1,219
-21% -$73.2K 0.17% 274
2022
Q1 		$365K Buy
+5,687
New +$374K 0.3% 149

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

MQS Management's IART Position: Q2 2024 in Review

MQS Management sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 5,731 shares — an estimated $203K sold.

MQS Management first reported a position in IART in Q1 2022 and held it in 4 quarters. The position peaked at $365K in Q1 2022. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • MQS Management reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • MQS Management sold 5,731 Integra LifeSciences shares in Q2 2024, an estimated $203K.
  • MQS Management first reported a position in Integra LifeSciences in Q1 2022 and held it in 4 quarters.
  • MQS Management's Integra LifeSciences position peaked at $365K in Q1 2022.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on MQS Management's 13F filing for Q2 2024, filed 12 Aug 2024.